He also has a very competent and nice staff
AOD 9604 (Anti-Obesity Drug 9604) is a modified derivative of HGH Fragment 176-191, originally developed by an Australian pharmaceutical company as a candidate compound for obesity research
Recommendations are written so that competitor products meeting the same criteria would qualify
Washout periods matter when designing sequential research protocols
The current adult weight-reduction label allows 7.2 mg after at least four weeks at 2.4 mg when additional loss is clinically indicated, and STEP UP measured more weight loss at 7.2 mg than at 2.4 mg. Side effects rise along the same curve
PubMed Marso, S.P., Bain, S.C., Consoli, A., Eliaschewitz, F.G., Jdar, E., Leiter, L.A., et al